Editorial content

BioPharma Dealmakers March 2016 edition

Our first edition of 2016 is now available. This spring issue explores the search for immuno-oncology combination therapies and includes a number of profiles from companies developing new technologies in the oncology field.

Go to the profile of Raveena Bhambra
Mar 07, 2016
2
0
Upvote 2 Comment

Read the March 2016 edition of BioPharma Dealmakers....

Read about the companies looking for partnerships from our March edition -

Andes Biotechnologies

InDanio BioSciences Inc.

ISA Pharma

MyCartis

OncoQuest Inc.

OncoSec

OncoTherapy Science

Synaffix

Read the in-depth partnering feature from our March edition -

Immuno-oncology dominates big pharma’s deal agenda

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.
28 Contributions
84 Followers
21 Following

Please sign in or register for FREE to comment